WHAT IS THE EVIDENCE FOR MEDICAL MARIJUANA TO TREAT THE ADDICTION EPIDEMIC?

Bottom of Form

The Marijuana Policy Project promotes their drug as a substitute for opiate pain pills.  Like the worst offenders in the opiate industry, the cannabis lobby follows an addiction-for-profit business model. Their master plan needs 80% of the demand to be met by 20% of the users.  Science shows no evidence for using medical marijuana as a substitute for pain pills.

Governor David Ige of Hawaii wisely refused to cave to lobbyists, and he vetoed a measure that would have allowed medical marijuana to treat opiate addiction.

large-scale, major study from Australia demonstrates that cannabis doesn’t work as a substitute for opiate pills in instances of chronic, non-cancer pain.  The study came out in July, 2018 and it supports the findings of an American study published in September, 2017.

The three-year research  study by Olfson, Wall et. al., Cannabis use and the Risk of Prescription Opioid Use Disorder, 2018, concluded: “Cannabis use appears to increase rather than decrease the risk of developing nonmedical prescription opioid use and opioid use disorder.”   More than a year ago, Dr. Ken Finn, professional advisorto Parents Opposed to Pot, published Current Research on Marijuana in Pain is lacking.

It seems we should NOT be encouraging “medical” marijuana use if our goal is to stop  addiction. Theodore Caputi and Keith Humphreys recently published in the Journal of Addiction: Medical marijuana users are more likely to use prescription drugs medically and nonmedically.  They concluded: “Medical marijuana users should be a target population in efforts to combat nonmedical prescription drug use.”   See our page on Marijuana vs. Pain Pills.

The Canadian Family Physicians wrote an editorial about Medical Marijuana in February, 2018, p. 87, after devoting an entire issue to the journal on medical marijuana.  Like the NAS report in the United States, the Canadian physicians reviewed hundreds of relevant studies. In the editorial, they concluded:

“Evidence indicates the most consistent effects of medical cannabinoids are adverse events.  A variety of adverse events have a greater magnitude of effect than the potential benefits for the conditions targeted.

Read the Clinical Conundrum of Medical Marijuana for more information. Dr. Ken Finn treats pain patients at of Springs Rehab in Colorado Springs.  He advises that there are more than 600 drug interactions with medical marijuana.   Are any medical marijuana dispensaries giving these warnings?  Another Colorado doctor who advocates marijuana for pain recently stated that marijuana edibles and concentrates should be banned.

 

For complete article http://www.poppot.org/2018/08/18/slim-evidence-medical-marijuana-for-opiates/

 

Thinking About Dropping Marijuana From Your Drug Test?

Some employers may be thinking about dropping marijuana from their drug testing panel as a way to address legalization. Learn about what to consider before making any changes to your drug-free workplace program in a short video produced by our friends at Drug Free Business.

https://youtu.be/ExvaVePrKYs

Thinking About Dropping Marijuana From Your Drug Test?

 

\"\"
\"\"
Drug overdoses
killed 72,306 Americans last year

The US government does not track death rates for every drug, but the National Center for Health Statistics and the Centers for Disease Control and Prevention collect information on many commonly used drugs. CDC has a searchable database, Wonder, from which these numbers come. The National Institute on Drug Abuse has graphed them to help the public see what a serious problem our nation faces. We reproduce them here to help spread the word.

Not all of these deaths are due to opioids, as later graphs below will show. Each graph contains a yellow and orange line indicating female (yellow) and male (orange) deaths. The lines end in 2016 because 2017 data are provisional. They will be finalized later this year.

Total drug-related deaths have increased 3.1-fold since 2002.

See total series here.


\"\"
Opioid overdoses
killed 49,068 Americans last year

Some 49,068 Americans died from opioid overdoses last year. These numbers include opioid painkillers, heroin, and illicit opioid synthetics, primarily fentanyl.

Note: These charts are not mutually exclusive so they cannot be summed.

See total series here.


\"\"
Overdoses from synthetic opioids, primarily fentanyl, killed 29,406 Americans last year.

These overdose deaths are up by one-third in just one year (from 2016 to 2027). There has been a 22-fold increase in synthetic opioid deaths since 2002.

Note: These charts are not mutually exclusive so they cannot be summed.

See total series here.


\"\"
Heroin overdoses
killed 15,958 Americans last year

This is a 7.6-fold increase since 2002.

Note: These charts are not mutually exclusive so they cannot be summed.

See total series here.


\"\"
Cocaine overdoses
killed 14,556 Americans last year

Since 2010, cocaine deaths have increased 3.5-fold.

Note: These charts are not mutually exclusive so they cannot be summed.

See total series here.


\"\"
Benzodiazepine overdoses
killed 10,684 Americans last year.

From 2002 to 2016 there was an 8-fold increase in benzodiazepine overdose deaths.

Note: These charts are not mutually exclusive so they cannot be summed.

See total series here.


\"\"
New wave of complex street drugs
puzzles emergency doctors.
Study may fuel need for
more comprehensive drug testing in hospitals.
Researchers set out in 2016 to identify the kinds of illicit drugs causing overdoses in patients presenting at the University of Maryland Medical Center Midtown Campus in Baltimore and the University of Maryland Prince George’s Hospital Center in Cheverly, a suburb of Washington. The researchers, from the Center for Substance Abuse Research (CESAR), were generating reports about patterns of drug use in the criminal justice system and they decided to apply their technique to hospitals.

At the time, emergency department physicians at the two hospitals were dealing with an increase in accidental overdoses and deaths they thought were caused by the synthetic marijuana product called K2 or Spice. Working with these doctors, the researchers analyzed de-identified urine specimens and linked them to de-identified patient medical records at the two hospitals. The urine specimens were tested for 26 synthetic cannabinoids, 59 designer drugs, and 84 other illicit and prescription drugs.
\”’We were thoroughly amazed that in a study where we thought everyone was having a synthetic cannabinoid-related problem, only one specimen tested positive for synthetic cannabinoids,’ says principal investigator Eric Wish, PhD, Director of CESAR at the University of Maryland, College Park, College of Behavioral & Social Sciences.”

About a year later, the lab expanded its tests for synthetic cannabinoids from 26 to 46 metabolites, but only a quarter of the samples tested positive for synthetic cannabinoids, much smaller than anticipated.

Marijuana was the most common individual drug detected in the urine specimens. From a fifth to a third of specimens at each hospital also tested positive for a new substance other than synthetic cannabinoids. Two thirds of patients at both hospitals tested positive for multiple substances; some specimens contained as many as six different kinds. After marijuana, fentanyl was the drug most frequently present in Baltimore specimens while PCP was the second-most frequent substance in specimens in Cheverly.

The researchers conclude that drug use is a much more complex problem than previously thought.

Read Science Daily article here. Download full report here.


\"\"
America’s Invisible Pot Addicts
More and more Americans are reporting near-constant
cannabis use, as  legalization forges ahead.

The number of adults with a marijuana-use disorder has doubled since the early 2000s, and the number who consume pot daily or near-daily has increased nearly 50 percent. This worries public health officials concerned about “increasingly permissive cannabis legislation, attitudes, and lower risk of perception,” as well as “increasingly potent options available, and the striking number of constant users.”

Users or former users describe “lost jobs, lost marriages, lost houses, lost money, lost time. Foreclosures and divorces. Weight gain and mental-health problems,” writes the author of this article in The Atlantic. Perhaps the biggest problem for such users is having to convince others that the problems they are suffering result from their marijuana-use disorders.

Experts worry that the way states are regulating legal marijuana invites such problems. Says Keith Humphreys, professor of psychiatry and behavioral sciences at Stanford University, “’Here, what we’ve done is we’ve copied the alcohol industry fully formed, and then on steroids with very minimal regulation. The oversight boards of a number of states are the industry themselves. We’ve learned enough about capitalism to know that’s very dangerous.”

Many improvements could be made, including most importantly “listening to and believing the hundreds of thousands of users who argue marijuana use is not always benign.”

Read The Atlantic article here.


\"\"
More women are using pot during pregnancy.
Here’s one reason why.

Pregnant women with severe nausea and vomiting in their first trimester were nearly four times more likely to use marijuana than those without morning sickness. Those with milder symptoms were twice as likely to use the drug as those with no symptoms.

More than 220,000 pregnant women in northern California completed surveys and submitted urine samples for drug screening in their first trimester. Researchers analyzed these data and also examined the participants’ medical records, looking for diagnoses of mild to severe morning sickness.

Some 2.3 percent of the women had severe nausea and vomiting; another 15.3 percent had milder symptoms. The rest experienced none. Among those with severe symptoms, 11.3 percent used marijuana and among those with mild symptoms, 8.4 percent used the drug compared to 4.5 percent who used marijuana but had no symptoms.

The researchers say they hope their study will encourage clinicians to provide safe and effective medicines to treat morning sickness. They also encourage clinicians to educate pregnant women about the negative effects that using marijuana during pregnancy may have on their babies, noting that the American College of Obstetricians and Gynecologists recommends that women use no marijuana during pregnancy and lactation.

Read Live Science article here. Read JAMA Internal Medicine abstract here.


\"\"
The Marijuana Report is a weekly e-newsletter published by National Families in Action in partnership with SAM (Smart Approaches to Marijuana).

Visit National Families in Action\’s website, The Marijuana Report.Org, to learn more about the marijuana story unfolding across the nation.

Subscribe to The Marijuana Report.


\"\"
Our mission is to protect children from addictive drugs
by shining light on the science that underlies their effects.

Addictive drugs harm children, families, and communities.
Legalizing them creates commercial industries that make drugs more available,
increase use, and expand harms.

Science shows that addiction begins in childhood.
It is a pediatric disease that is preventable.

We work to prevent the emergence of commercial
addictive drug industries that will target children.

We support FDA approved medicines.

We support the assessment, treatment, and/or social and educational services
for users and low-level dealers as alternatives to incarceration.


\"\"
About SAM (Smart Approaches to Marijuana)
SAM is a nonpartisan alliance of lawmakers, scientists and other concerned citizens who want to move beyond simplistic discussions of \”incarceration versus legalization\” when discussing marijuana use and instead focus on practical changes in marijuana policy that neither demonizes users nor legalizes the drug. SAM supports a treatment, health-first marijuana policy.  SAM has four main goals:
  • To inform public policy with the science of today\’s marijuana.
  • To reduce the unintended consequences of current marijuana policies, such as lifelong stigma due to arrest.
  • To prevent the establishment of \”Big Marijuana\” – and a 21st-Century tobacco industry that would market marijuana to children.
  • To promote research of marijuana\’s medical properties and produce, non-smoked, non-psychoactive pharmacy-attainable medications.

 

HIGHLY TOXIC CANNABIS IN MASS?

GLOBAL NEWS CENTRE

\"\"

Contaminated flower may be getting patients and employees sick

Anne Hassel had high hopes for a new career when she applied for a job serving medical marijuana patients at New England Treatment Access (NETA), a registered medical dispensary (RMD) in Massachusetts. A licensed physical therapist, she believes in the efficacy of cannabis and says that she appreciated how NETA was presented “as having a new business paradigm, one of worker input and responsive management.”

That was then. Now, nearly a year after she quit working at NETA and filed a complaint with the Occupational Safety and Health Administration (OSHA) claiming she was regularly exposed to mold via cannabis flower, Hassel mockingly says NETA stands for “Never Ethically Treating Anybody.”

“Mold was an issue at both [NETA’s] Franklin cultivation center and the Northampton dispensary,” Hassel wrote in her complaint to OSHA. The former budtender reported that she “observed powered mildew flower” while trimming cannabis in 2016 in Franklin but was instructed by a supervisor to “cut around it.” She also says that management dunked “marijuana flower into a hydrogen peroxide solution to treat the mold.”

In response to a request for comment, a NETA spokesperson wrote, “Our product is tested for mold, yeast, bacterial and other biological pathogens, by independent laboratories… No product is delivered to the dispensaries that has not passed state testing protocols.” Regarding hydrogen peroxide, the spokesperson offered information that was previously unavailable in the company’s response to regulators: “NETA has been open and public about our use. The [response to Hassel’s OSHA complaint] pertained to our Northampton RMD and would be misapplied when discussing our harvest practices.”

For complete story http://www.globalnewscentre.com/highly-toxic-cannabis-in-mass/#sthash.hr45lBso.dpbs%20https://digboston.com/is-there-moldy-cannabis-in-mass/

 

International Overdose Day 2018 — Prevent Don’t Promote

This day of acknowledgement and focus around illicit drug overdose issues, should be — must be — about the prevention, repair and/or cessation of all that leads to an overdose episode, not merely the survival of it! …

It is important to reiterate that, a very real danger of this emerging narrative, is that it only entrenches victimhood and habit in unaccountable modes, ensuring personal agency and capacity are further deprived from the self, family and community harming individual! …

Trauma must be properly defined, properly managed and recovery from cause and symptom inexorably perused with best-practice mechanisms at all levels. Best-practice that precludes all self-medicating/harming processes, as they are all counterproductive in the restorative journey…

It’s also important to delineate between uptake of Heroin and the uptake of other illicit drugs. Our organisations connections in the sector have revealed that the majority of those ‘engaging’ directly with heroin were those who had suffered sexual abuse of some kind, particularly when young. However, we must be careful not to fall for the emotional overcategorization of triggers, prompts and ‘incentives’ for the far wider uptake of illicit drugs.

For complete article go to International Overdose Awareness Day 2018

Fight Drug Abuse, Don’t Subsidize It

Americans struggling with addiction need treatment and reduced access to deadly drugs. They do not need a taxpayer-sponsored haven to shoot up.

Almost 64,000 Americans died of drug overdoses in 2016, a shocking 54 percent increase since 2012. Dangerous opioids such as heroin and fentanyl contributed to two-thirds of the deaths. This killer knows no geographic, socioeconomic or age limits. It strikes city dwellers and Midwestern farmers, Hollywood celebrities and homeless veterans, grandparents and teenagers.

Remarkably, law enforcement efforts actually declined while deaths were on the rise. Federal drug prosecutions fell by 23 percent from 2011 to 2016, and the median drug sentence doled out to drug traffickers decreased by 20 percent from 2009 to 2016.

The Trump administration is working to reverse those trends. Prosecutions of drug traffickers are on the rise, and the surge in overdose deaths is slowing.

Unfortunately, some cities and counties are considering sponsoring centers where drug users can abuse dangerous illegal drugs with government help. Advocates euphemistically call them “safe injection sites,” but they are very dangerous and would only make the opioid crisis worse.

These centers would be modeled on those operating in Canada and some European countries. They invite visitors to use heroin, fentanyl and other deadly drugs without fear of arrest. The policy is “B.Y.O.D.” – bring your own drugs – but staff members help people abuse drugs by providing needles and stand ready to resuscitate addicts who overdose.

Aug. 27, 2018 By Rod J. Rosensteindeputy attorney general of the United States. For complete article go to New York Times Opinion — Shooting Galleries

 

 

With cannabis coming to the workplace, what constitutes ‘impairment’?

ANDREW AU AUGUST 10, 2018  President, Intercept Group

Just as digital transformation has disrupted legacy business models, cannabis legalization will fundamentally challenge workplace policies.

On Oct. 17, recreational marijuana will officially become legal in Canada. According to a recent study conducted by Deloitte, 22 per cent of the Canadian adult population consumes recreational cannabis at least occasionally, and a further 17 per cent show some willingness to try it.

When we look at the single largest generation in the work force — millennials born between 1980 and 2000 — we see even higher receptivity. A national millennial study conducted by Intercept revealed that nearly three-quarters of respondents agree with the legalization of cannabis. And, they’re eager to try a variety of formats, including marijuana-infused baked food (52 per cent), skin lotions (49 per cent), candy (40 per cent) and vapour (38 per cent). Interestingly, while the majority of millennials agree with legalization, they also have concerns. Nearly 40 per cent believe it may lead to poorer performance at work.

Like it or not, cannabis consumption is about to spike. The total number of Canadians who’ve already registered for medical marijuana use exceeded 270,000 in December, 2017, according to Health Canada.

If you’re concerned about the implication of cannabis legalization, you’re in good company. In a report by the Conference Board of Canada, more than half of Canadian employers expressed concern about the implications of legalized marijuana on the workplace.

Cannabis will force company leaders to rethink existing workplace policies and implement new ones to ensure they’re offering a safe, inclusive and productive environment.

For complete article https://beta.theglobeandmail.com/cannabis/article-with-cannabis-coming-to-the-workplace-what-constitutes-impairment/

 

\"\"

Dear friend,

Because of the hard work of diligent supporters such as yourself, the SAM family has been able to push back the efforts of the pot industry in states across the country this year.
So far this year, legalization and commercialization attempts have failed due to the perseverance of SAM affiliates and partners in Illinois, Vermont, Connecticut, New Hampshire, Delaware, Oklahoma, and Rhode Island.
In Rhode Island, our partners have been extremely successful in fighting back Big Marijuana\’s attempt to expand into the state. Their tireless efforts have resulted in legalization bills being defeated in the General Assembly every year for the last seven years. Last year, they defeated attempts to divert funds meant for regulation of the state\’s medical marijuana program to the general fund.
Additionally, they have defeated numerous attempts to expand the number of marijuana dispensaries and have succeeded in establishing local control over pot-related zoning ordinances in towns and cities. When the state was rushing to legalize pot, our partners were able to orchestrate the creation of a bi-partisan group to study the potential impacts of legalization on the state.
But even with our successes this year and in years past, we simply must do more.
Big Marijuana is determined to do whatever it takes to shove its reckless and dangerous agenda down our throats, but as detailed above, legalization is not a forgone conclusion.
We can\’t all leave our jobs to dedicate our lives to advocacy like I did and like others are so graciously doing, but we can pick up the phone and call our elected officials and let them know we will not stand quietly on the sidelines while they sell our country out to Big Marijuana.
We can all write a letter to the editor or an op-ed highlighting how legalization has led to an increase in drugged driving and in youth exposure to pot. Here is an example of an op-ed recently published in California on  drugged-driving, another in  The Hill focusing on marijuana banking, and one recently published in the Wall Street Journal highlighting the  harms of legalization.
Even if you don\’t have the time to do any of those, or maybe you just don\’t want to publicly be involved, you can still help bychipping in to the fight.
Will you take action today to stand with us?
Thank you again for everything you do,
\"\"
Dr. Kevin Sabet
Founder and President
Smart Approaches to Marijuana Action

 

LIFE OR DEATH AFTER A NON-FATAL DRUG OVERDOSE

Research studies (see Stoové et al, 2009) have long associated surviving a drug overdose with the increased likelihood of a future non-fatal or fatal drug overdose. In a 2017 Massachusetts study of opioid overdoses, 10% of those who survived died within the next year from a drug overdose or other causes. In one of the most rigorous U.S. follow-up studies, Dr. Mark Olfson and colleagues compared the mortality rates of people who had survived a non-fatal opioid overdose to demographically matched members of the general U.S. population. They found that those who survived an opioid overdose died in the next year at 24 times the mortality rate of those in the general population, with most deaths attributed to drug-related diseases, subsequent overdose, circulatory disease, respiratory disease, cancer, HIV, viral hepatitis, and suicide. In another study that might be christened an investigation into lost opportunities, Dr. Linn Gjersing and colleagues found in a retrospective analysis of people who died of a drug overdose that 61% had previously sought emergency medical care and that 18% were frequent users of emergency medical services. The reasons for seeking past emergency care included somatic complaints (48%), injury (44%), alcohol and other drug-related medical problems (32%), and drug overdose (26%).

For complete article http://www.williamwhitepapers.com/blog/2018/08/life-or-death-after-a-non-fatal-drug-overdose.html

This is just one of the reasons why it is vital to divert drug users into recovery programs, not simply enable and equip them to continue self-harming with substances — These drug use endorsing mechanisms only increase the risk of harm that the same so-called ‘harm reduction’ strategies are supposed to lessen! (D.I. Comment)

 

TWO FRIENDS: QUITTING POT SENT ME IN ANOTHER DIRECTION

AUGUST 2018

(Read part 1) This is how two friends changed forever.  I was 19, with spotty employment, working low level part-time jobs. Sometimes I was “involuntarily terminated” from jobs because of poor attendance or petty theft. I did not understand at the time the awful effects that near daily use of marijuana was exerting on me. I had become a different person.

At age 19, I was diagnosed with clinical depression by a psychiatrist. Looking back from the much wiser perspective of mature man, I am absolutely certain that my depression was triggered directly by my regular cannabis use.

I had wanted to join the U.S. Navy immediately after high school because I’d wanted to “see the world.” But a neighborhood guy, another doper and USN veteran with a bad conduct discharge, had talked me out of it. He told me I’d most likely get involved with hard drugs if I did. I took his advice because I was not mentally strong enough to make decisions and stand on my own two feet. Cannabis had turned my mind into mush.

For complete story http://www.poppot.org/2018/08/13/two-friends-meet-go-different-directions/

 

Scroll to Top